SEC Form 4 research
| Issuer | InMed Pharmaceuticals Inc. |
|---|---|
| Tickers | INM |
| Reporting owners | 25 |
| Officers and directors | 5 |
| Last public filing | 2026-10-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-15 | 2026-10-15 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 984 | $1.32 | Not reported |
| 2026-10-15 | 2026-10-14 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 8,021 | $1.33 | Not reported |
| 2026-10-15 | 2026-10-13 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 564 | $1.33 | Not reported |
| 2026-10-08 | 2026-10-08 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 2,256 | $1.33 | Not reported |
| 2026-10-08 | 2026-10-07 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 3,046 | $1.33 | Not reported |
| 2026-10-08 | 2026-10-06 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 5,601 | $1.33 | Not reported |
| 2026-10-05 | 2026-10-05 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 18,182 | $1.33 | Not reported |
| 2026-10-05 | 2026-10-02 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 8,307 | $1.33 | Not reported |
| 2026-10-05 | 2026-10-01 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 16,431 | $1.33 | Not reported |
| 2026-09-16 | 2026-09-16 | ADAR1 Capital Management, LLC, Schneeberger Daniel | P | 8,340 | $1.29 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.